The regulation of endocrine-disrupting chemicals to minimize their impact on health.


Journal

Nature reviews. Endocrinology
ISSN: 1759-5037
Titre abrégé: Nat Rev Endocrinol
Pays: England
ID NLM: 101500078

Informations de publication

Date de publication:
10 2023
Historique:
accepted: 29 06 2023
medline: 13 9 2023
pubmed: 9 8 2023
entrez: 8 8 2023
Statut: ppublish

Résumé

Endocrine-disrupting chemicals (EDCs) are substances generated by human industrial activities that are detrimental to human health through their effects on the endocrine system. The global societal and economic burden posed by EDCs is substantial. Poorly defined or unenforced policies can increase human exposure to EDCs, thereby contributing to human disease, disability and economic damage. Researchers have shown that policies and interventions implemented at both individual and government levels have the potential to reduce exposure to EDCs. This Review describes a set of evidence-based policy actions to manage, minimize or even eliminate the widespread use of these chemicals and better protect human health and society. A number of specific challenges exist: defining, identifying and prioritizing EDCs; considering the non-linear or non-monotonic properties of EDCs; accounting for EDC exposure effects that are latent and do not appear until later in life; and updating testing paradigms to reflect 'real-world' mixtures of chemicals and cumulative exposure. A sound strategy also requires partnering with health-care providers to integrate strategies to prevent EDC exposure in clinical care. Critical next steps include addressing EDCs within global policy frameworks by integrating EDC exposure prevention into emerging climate policy.

Identifiants

pubmed: 37553404
doi: 10.1038/s41574-023-00872-x
pii: 10.1038/s41574-023-00872-x
doi:

Substances chimiques

Endocrine Disruptors 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

600-614

Informations de copyright

© 2023. Springer Nature Limited.

Références

Carson R., Lear L., Wilson E. O. Silent Spring Anniversary edition (Houghton Mifflin, 2002).
Herbst, A. L., Ulfelder, H. & Poskanzer, D. C. Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. N. Engl. J. Med. 284, 878–881 (1971).
pubmed: 5549830 doi: 10.1056/NEJM197104222841604
Attina, T. M. et al. Exposure to endocrine-disrupting chemicals in the USA: a population-based disease burden and cost analysis. Lancet Diabetes Endocrinol. 4, 996–1003 (2016).
pubmed: 27765541 doi: 10.1016/S2213-8587(16)30275-3
Hotchkiss, A. K. et al. Fifteen years after “Wingspread” — environmental endocrine disrupters and human and wildlife health: where we are today and where we need to go. Toxicol. Sci. 105, 235–259 (2008).
pubmed: 18281716 pmcid: 2721670 doi: 10.1093/toxsci/kfn030
World Health Organization. State of the Science of Endocrine Disrupting Chemicals. Inter-Organization Programme for the Sound Management of Chemicals https://apps.who.int/iris/handle/10665/78101 (2013).
Diamanti-Kandarakis, E. et al. Endocrine-disrupting chemicals: an Endocrine Society scientific statement. Endocr. Rev. 30, 293–342 (2009).
pubmed: 19502515 pmcid: 2726844 doi: 10.1210/er.2009-0002
Gore, A. C. et al. EDC-2: The Endocrine Society’s second scientific statement on endocrine-disrupting chemicals. Endocr. Rev. 36, E1–E150 (2015). This manuscript remains the most authoritative review and analysis of the effects of EDCs on health outcomes.
pubmed: 26544531 pmcid: 4702494 doi: 10.1210/er.2015-1010
Trasande, L., Shaffer, R. M. & Sathyanarayana, S. Food additives and child health. Pediatrics 142, e20181410 (2018).
pubmed: 30037972 doi: 10.1542/peds.2018-1410
Di Renzo, G. C. et al. International Federation of Gynecology and Obstetrics opinion on reproductive health impacts of exposure to toxic environmental chemicals. Int. J. Gynaecol. Obstet. 131, 219–225 (2015).
pubmed: 26433469 pmcid: 6663094 doi: 10.1016/j.ijgo.2015.09.002
Malits, J., Naidu, M. & Trasande, L. Exposure to endocrine disrupting chemicals in Canada: population-based estimates of disease burden and economic costs. Toxics 10, 146 (2022).
pubmed: 35324771 pmcid: 8948756 doi: 10.3390/toxics10030146
Bellanger, M., Demeneix, B., Grandjean, P., Zoeller, R. T. & Trasande, L. Neurobehavioral deficits, diseases, and associated costs of exposure to endocrine-disrupting chemicals in the European Union. J. Clin. Endocrinol. Metab. 100, 1256–1266 (2015).
pubmed: 25742515 pmcid: 4399309 doi: 10.1210/jc.2014-4323
Hauser, R. et al. Male reproductive disorders, diseases, and costs of exposure to endocrine-disrupting chemicals in the European Union. J. Clin. Endocrinol. Metab. 100, 1267–1277 (2015).
pubmed: 25742517 pmcid: 4399287 doi: 10.1210/jc.2014-4325
Hunt, P. A., Sathyanarayana, S., Fowler, P. A. & Trasande, L. Female reproductive disorders, diseases, and costs of exposure to endocrine disrupting chemicals in the European Union. J. Clin. Endocrinol. Metab. 101, 1562–1570 (2016).
pubmed: 27003299 pmcid: 4880176 doi: 10.1210/jc.2015-2873
Legler, J. et al. Trasande L. Obesity, diabetes, and associated costs of exposure to endocrine-disrupting chemicals in the European Union. J. Clin. Endocrinol. Metab. 100, 1278–1288 (2015).
pubmed: 25742518 pmcid: 4399302 doi: 10.1210/jc.2014-4326
Trasande, L. et al. Estimating burden and disease costs of exposure to endocrine-disrupting chemicals in the European union. J. Clin. Endocrinol. Metab. 100, 1245–1255 (2015). The first assessment demonstrating that EDC exposures were contributing to significant cost burdens.
pubmed: 25742516 pmcid: 4399291 doi: 10.1210/jc.2014-4324
Trasande, L. et al. Burden of disease and costs of exposure to endocrine disrupting chemicals in the European Union: an updated analysis. Andrology 4, 565–572 (2016).
pubmed: 27003928 pmcid: 5244983 doi: 10.1111/andr.12178
Obsekov, V., Kahn, L. G. & Trasande, L. Leveraging systematic reviews to explore disease burden and costs of per- and polyfluoroalkyl substance exposures in the United States. Expo. Health 15, 373–394 (2023).
pubmed: 37213870 doi: 10.1007/s12403-022-00496-y
Trasande, L., Liu, B. & Bao, W. Phthalates and attributable mortality: a population-based longitudinal cohort study and cost analysis. Environ. Pollut. 292, 118021 (2022).
pubmed: 34654571 doi: 10.1016/j.envpol.2021.118021
Ruiz, D., Becerra, M., Jagai, J. S., Ard, K. & Sargis, R. M. Disparities in environmental exposures to endocrine-disrupting chemicals and diabetes risk in vulnerable populations. Diabetes Care 41, 193–205 (2018).
pubmed: 29142003 doi: 10.2337/dc16-2765
Abellan, A. et al. In utero exposure to bisphenols and asthma, wheeze, and lung function in school-age children: a prospective meta-analysis of 8 European birth cohorts. Environ. Int. 162, 107178 (2022).
pubmed: 35314078 doi: 10.1016/j.envint.2022.107178
Lam, J. et al. The navigation guide — evidence-based medicine meets environmental health: integration of animal and human evidence for PFOA effects on fetal growth. Environ. Health Perspect. 122, 1040–1051 (2014).
pubmed: 24968389 pmcid: 4181930 doi: 10.1289/ehp.1307923
Fan, X. et al. Global exposure to per- and polyfluoroalkyl substances and associated burden of low birthweight. Environ. Sci. Technol. 56, 4282–4294 (2022).
pubmed: 35293723 doi: 10.1021/acs.est.1c08669
Barbosa, K. L. et al. Tributyltin and the female hypothalamic-pituitary-gonadal disruption. Toxicol. Sci. 186, 179–189 (2022).
pubmed: 34850235 doi: 10.1093/toxsci/kfab141
Uc-Peraza, R. G., Castro, Í. B. & Fillmann, G. An absurd scenario in 2021: banned TBT-based antifouling products still available on the market. Sci. Total Environ. 805, 150377 (2022).
pubmed: 34818813 doi: 10.1016/j.scitotenv.2021.150377
Trasande, L. When enough data are not enough to enact policy: the failure to ban chlorpyrifos. PLoS Biol. 15, e2003671 (2017).
pubmed: 29267272 pmcid: 5739382 doi: 10.1371/journal.pbio.2003671
Malo, S. 3M, others reach $65 mln deal with NY town over PFOA in drinking water. Reuters https://www.reuters.com/legal/litigation/3m-others-reach-65-mln-deal-with-ny-town-over-pfoa-drinking-water-2021-07-22/ (2021).
Bradman, A. et al. Effect of organic diet intervention on pesticide exposures in young children living in low-income urban and agricultural communities. Environ. Health Perspect. 123, 1086–1093 (2015). An outstanding intervention study showing that lifestyle changes can impact exposures to EDCs.
pubmed: 25861095 pmcid: 4590750 doi: 10.1289/ehp.1408660
Harley, K. G. et al. Reducing phthalate, paraben, and phenol exposure from personal care products in adolescent girls: findings from the HERMOSA intervention study. Environ. Health Perspect. 124, 1600–1607 (2016).
pubmed: 26947464 pmcid: 5047791 doi: 10.1289/ehp.1510514
Rudel, R. A. et al. Food packaging and bisphenol A and bis(2-ethyhexyl) phthalate exposure: findings from a dietary intervention. Environ. Health Perspect. 119, 914–920 (2011).
pubmed: 21450549 pmcid: 3223004 doi: 10.1289/ehp.1003170
Young, A. S. et al. Impact of “healthier” materials interventions on dust concentrations of per- and polyfluoroalkyl substances, polybrominated diphenyl ethers, and organophosphate esters. Environ. Int. 150, 106151 (2021).
pubmed: 33092866 doi: 10.1016/j.envint.2020.106151
Li, R. et al. Temporal trends in risk of bisphenol A, benzophenone-3 and triclosan exposure among U.S. children and adolescents aged 6-19 years: findings from the National Health and Nutrition Examination Survey 2005-2016. Environ. Res. 216, 114474 (2023).
pubmed: 36202243 doi: 10.1016/j.envres.2022.114474
Zoeller, R. T. et al. A path forward in the debate over health impacts of endocrine disrupting chemicals. Environ. Health 13, 118 (2014).
pubmed: 25533907 pmcid: 4298083 doi: 10.1186/1476-069X-13-118
International Programme on Chemical Safety. Global Assessment of the State of the Science of Endocrine Disruptors. World Health Organization https://apps.who.int/iris/handle/10665/67357 (2002).
Woodruff, T. J. et al. Meeting report: moving upstream-evaluating adverse upstream end points for improved risk assessment and decision-making. Environ. Health Perspect. 116, 1568–1575 (2008).
pubmed: 19057713 pmcid: 2592280 doi: 10.1289/ehp.11516
Maffini, M. V. & Vandenberg, L. N. Failure to launch: the endocrine disruptor screening program at the U.S. Environmental Protection Agency. Front. Toxicol. 4, 908439 (2022). A new analysis demonstrating how and why the EPA screening programme for EDCs has failed to protect the public from chemicals with endocrine-disrupting properties.
pubmed: 35707496 pmcid: 9189695 doi: 10.3389/ftox.2022.908439
Knudsen, T. B. et al. FutureTox II: in vitro data and in silico models for predictive toxicology. Toxicol. Sci. 143, 256–267 (2015).
pubmed: 25628403 pmcid: 4318934 doi: 10.1093/toxsci/kfu234
Malo, N., Hanley, J. A., Cerquozzi, S., Pelletier, J. & Nadon, R. Statistical practice in high-throughput screening data analysis. Nat. Biotechnol. 24, 167–175 (2006).
pubmed: 16465162 doi: 10.1038/nbt1186
Richard, A. M. et al. ToxCast chemical landscape: paving the road to 21st century toxicology. Chem. Res. Toxicol. 29, 1225–1251 (2016).
pubmed: 27367298 doi: 10.1021/acs.chemrestox.6b00135
Environmental Protection Agency. Availability of New Approach Methodologies (NAMs) in the Endocrine Disruptor Screening Program (EDSP) https://www.regulations.gov/document/EPA-HQ-OPP-2021-0756-0002 (2023).
European Agency for Safety and Health at Work. Regulation (EC) No 1907/2006 — Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH). Safety and Health at Work EU-OSHA https://osha.europa.eu/en/legislation/directives/regulation-ec-no-1907-2006-of-the-european-parliament-and-of-the-council (2021).
Endocrine Disruptor Lists. Substances Identified as Endocrine Disruptors at EU Level https://edlists.org/the-ed-lists/list-i-substances-identified-as-endocrine-disruptors-by-the-eu (2022).
Wang, Z., Walker, G. W., Muir, D. C. G. & Nagatani-Yoshida, K. Toward a global understanding of chemical pollution: a first comprehensive analysis of national and regional chemical inventories. Environ. Sci. Technol. 54, 2575–2584 (2020).
pubmed: 31968937 doi: 10.1021/acs.est.9b06379
Neltner, T. G. et al. Navigating the U.S. Food Additive Regulatory Program. Compr. Rev. Food Sci. Food Saf. 10, 342–368 (2011).
doi: 10.1111/j.1541-4337.2011.00166.x
Encarnação, T., Pais, A. A., Campos, M. G. & Burrows, H. D. Endocrine disrupting chemicals: Impact on human health, wildlife and the environment. Sci. Prog. 102, 3–42 (2019).
pubmed: 31829784 pmcid: 10424550 doi: 10.1177/0036850419826802
Neltner, T. G., Alger, H. M., Leonard, J. E. & Maffini, M. V. Data gaps in toxicity testing of chemicals allowed in food in the United States. Reprod. Toxicol. 42, 85–94 (2013).
pubmed: 23954440 doi: 10.1016/j.reprotox.2013.07.023
Janesick, A. S. et al. On the utility of ToxCast
pubmed: 26757984 pmcid: 4977052 doi: 10.1289/ehp.1510352
Filer, D., Patisaul, H. B., Schug, T., Reif, D. & Thayer, K. Test driving ToxCast: endocrine profiling for 1858 chemicals included in phase II. Curr. Opin. Pharmacol. 19, 145–152 (2014).
pubmed: 25460227 pmcid: 4297520 doi: 10.1016/j.coph.2014.09.021
NRDC. Court Rules EPA Must Regulate Perchlorate https://www.nrdc.org/press-releases/court-rules-epa-must-regulate-perchlorate (2023).
Filer, D. L., Hoffman, K., Sargis, R. M., Trasande, L. & Kassotis, C. D. On the utility of ToxCast-based predictive models to evaluate potential metabolic disruption by environmental chemicals. Env. Health Perspect. 130, 57005 (2022).
doi: 10.1289/EHP6779
Martin, M. T. et al. Predictive model of rat reproductive toxicity from ToxCast high throughput screening. Biol. Reprod. 85, 327–339 (2011).
pubmed: 21565999 doi: 10.1095/biolreprod.111.090977
Sipes, N. S. et al. Predictive models of prenatal developmental toxicity from ToxCast high-throughput screening data. Toxicol. Sci. 124, 109–127 (2011).
pubmed: 21873373 doi: 10.1093/toxsci/kfr220
Liu, J. et al. Predicting hepatotoxicity using ToxCast in vitro bioactivity and chemical structure. Chem. Res. Toxicol. 28, 738–751 (2015).
pubmed: 25697799 doi: 10.1021/tx500501h
Schwarzman, M. R. et al. Screening for chemical contributions to breast cancer risk: a case study for chemical safety evaluation. Environ. Health Perspect. 123, 1255–1264 (2015).
pubmed: 26032647 pmcid: 4671249 doi: 10.1289/ehp.1408337
Maffini, M. V., Trasande, L. & Neltner, T. G. Perchlorate and diet: human exposures, risks, and mitigation strategies. Curr. Environ. Health Rep. 3, 107–117 (2016).
pubmed: 27029550 doi: 10.1007/s40572-016-0090-3
EFSA. Public Consultation: Re-evaluation of the Risks to Public Health Related to the Presence of Bisphenol A (BPA) in Foodstuffs https://connect.efsa.europa.eu/RM/s/publicconsultation2/a0l1v00000E8BRD/pc0109 (2022).
EFSA Panel on Food Contact Materials, Enzymes and Processing Aids (CEP) et al. Re-evaluation of the risks to public health related to the presence of bisphenol A (BPA) in foodstuffs.EFSA J. 21, e06857 (2023).
FDA. GRAS Notices: Soy Isoflavone Extract https://www.cfsanappsexternal.fda.gov/scripts/fdcc/index.cfm?set=GRASNotices&id=1 (1998).
FDA. GRAS Notices: trans-Resveratrol https://www.cfsanappsexternal.fda.gov/scripts/fdcc/index.cfm?set=GRASNotices&id=224 (2007).
Maffini, M. V. & Neltner, T. G. How the FDA Ignores the Law When Approving New Chemical Additives to Food. Environmental Health News https://www.ehn.org/health-issues-associated-with-food-additives-2649620272.html (2020).
Maffini, M. V. et al. Advancing the science on chemical classes. Environ. Health 21, 120 (2023). A new policy analysis that reviews the approaches that are available to regulate environmental chemicals in classes rather than as individual chemicals.
pubmed: 36635752 pmcid: 9835214 doi: 10.1186/s12940-022-00919-y
Zimmermann, L. et al. Implementing the EU chemicals strategy for sustainability: the case of food contact chemicals of concern. J. Hazard. Mater. 437, 129167 (2022).
pubmed: 35897167 doi: 10.1016/j.jhazmat.2022.129167
Solecki, R. et al. Scientific principles for the identification of endocrine-disrupting chemicals: a consensus statement. Arch. Toxicol. 91, 1001–1006 (2017).
pubmed: 27714423 doi: 10.1007/s00204-016-1866-9
ANSES’s Working Group on Endocrine Disruptors et al. Concerns related to ED-mediated effects of Bisphenol A and their regulatory consideration. Mol. Cell Endocrinol. 475, 92–106 (2018).
doi: 10.1016/j.mce.2018.02.002
Vandenberg, L. N. et al. Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses. Endocr. Rev. 33, 378–455 (2012).
pubmed: 22419778 pmcid: 3365860 doi: 10.1210/er.2011-1050
Hill, C. E., Myers, J. P. & Vandenberg, L. N. Nonmonotonic dose–response curves occur in dose ranges that are relevant to regulatory decision-making. Dose Response 16, 1559325818798282 (2018).
pubmed: 30228814 pmcid: 6137554 doi: 10.1177/1559325818798282
Do, R. P., Stahlhut, R. W., Ponzi, D., Vom Saal, F. S. & Taylor, J. A. Non-monotonic dose effects of in utero exposure to di(2-ethylhexyl) phthalate (DEHP) on testicular and serum testosterone and anogenital distance in male mouse fetuses. Reprod. Toxicol. 34, 614–621 (2012).
pubmed: 23041310 pmcid: 3543148 doi: 10.1016/j.reprotox.2012.09.006
Lee, D. H. et al. Low dose of some persistent organic pollutants predicts type 2 diabetes: a nested case–control study. Environ. Health Perspect. 118, 1235–1242 (2010).
pubmed: 20444671 pmcid: 2944083 doi: 10.1289/ehp.0901480
Lanphear, B. P. et al. Low-level environmental lead exposure and children’s intellectual function: an international pooled analysis. Environ. Health Perspect. 113, 894–899 (2005).
pubmed: 16002379 pmcid: 1257652 doi: 10.1289/ehp.7688
Grandjean, P. et al. Methylmercury exposure biomarkers as indicators of neurotoxicity in children aged 7 years. Am. J. Epidemiol. 150, 301–305 (1999).
pubmed: 10430235 doi: 10.1093/oxfordjournals.aje.a010002
Bouchard, M. F. et al. Prenatal exposure to organophosphate pesticides and IQ in 7-year-old children. Environ. Health Perspect. 119, 1189–1195 (2011).
pubmed: 21507776 pmcid: 3237357 doi: 10.1289/ehp.1003185
Rauh, V. A. et al. Impact of prenatal chlorpyrifos exposure on neurodevelopment in the first 3 years of life among inner-city children. Pediatrics 118, e1845–e1859 (2006).
pubmed: 17116700 doi: 10.1542/peds.2006-0338
Mancini, F. R. et al. Nonlinear associations between dietary exposures to perfluorooctanoic acid (PFOA) or perfluorooctane sulfonate (PFOS) and type 2 diabetes risk in women: findings from the E3N cohort study. Int. J. Hyg. Environ. Health 221, 1054–1060 (2018).
pubmed: 30056006 doi: 10.1016/j.ijheh.2018.07.007
Chen, A. et al. Prenatal polybrominated diphenyl ether exposures and neurodevelopment in U.S. children through 5 years of age: the HOME study. Environ. Health Perspect. 122, 856–862 (2014).
pubmed: 24870060 pmcid: 4123029 doi: 10.1289/ehp.1307562
Herbstman, J. B. et al. Prenatal exposure to PBDEs and neurodevelopment. Environ. Health Perspect. 118, 712–719 (2010).
pubmed: 20056561 pmcid: 2866690 doi: 10.1289/ehp.0901340
Varshavsky, J. R. et al. Current practice and recommendations for advancing how human variability and susceptibility are considered in chemical risk assessment. Environ. Health 21, 133 (2023). A new policy analysis that illustrates best practices for using measures of variability and susceptibility in models for risk assessment.
pubmed: 36635753 pmcid: 9835253 doi: 10.1186/s12940-022-00940-1
Demeneix, B., Vandenberg, L. N., Ivell, R. & Zoeller, R. T. Thresholds and endocrine disruptors: an endocrine society policy perspective. J. Endocr. Soc. 4, bvaa085 (2020).
pubmed: 33834149 pmcid: 8010901 doi: 10.1210/jendso/bvaa085
Hall, A. M. & Braun, J. M. Per- and polyfluoroalkyl substances and outcomes related to metabolic syndrome: a review of the literature and current recommendations for clinicians. Am. J. Lifestyle Med. https://doi.org/10.1177/15598276231162802 (2023).
doi: 10.1177/15598276231162802
Jackson, A. A., Langley-Evans, S. C. & McCarthy, H. D. Nutritional influences in early life upon obesity and body proportions. CIBA Found. Symp. 201, 118–129 (1996).
pubmed: 9017278
Kahn, H. S., Graff, M., Stein, A. D. & Lumey, L. H. A fingerprint marker from early gestation associated with diabetes in middle age: the Dutch Hunger Winter Families Study. Int. J. Epidemiol. 38, 101–109 (2009).
pubmed: 18684786 doi: 10.1093/ije/dyn158
Schulz, L. C. The Dutch Hunger Winter and the developmental origins of health and disease. Proc. Natl Acad. Sci. USA 107, 16757–16758 (2010).
pubmed: 20855592 pmcid: 2947916 doi: 10.1073/pnas.1012911107
Ghassabian, A., Vandenberg, L., Kannan, K. & Trasande, L. Endocrine-disrupting chemicals and child health. Annu. Rev. Pharmacol. Toxicol. 62, 573–594 (2022).
pubmed: 34555290 doi: 10.1146/annurev-pharmtox-021921-093352
Newbold, R. R., Padilla-Banks, E., Snyder, R. J. & Jefferson, W. N. Perinatal exposure to environmental estrogens and the development of obesity. Mol. Nutr. Food Res. 51, 912–917 (2007).
pubmed: 17604389 doi: 10.1002/mnfr.200600259
Somm, E. et al. Perinatal exposure to bisphenol a alters early adipogenesis in the rat. Environ. Health Perspect. 117, 1549–1555 (2009).
pubmed: 20019905 pmcid: 2790509 doi: 10.1289/ehp.11342
Hao, C. J., Cheng, X. J., Xia, H. F. & Ma, X. The endocrine disruptor 4-nonylphenol promotes adipocyte differentiation and induces obesity in mice. Cell Physiol. Biochem. 30, 382–394 (2012).
pubmed: 22739433 doi: 10.1159/000339032
Patisaul, H. B. et al. Accumulation and endocrine disrupting effects of the flame retardant mixture Firemaster
pubmed: 23139171 doi: 10.1002/jbt.21439
Kassotis, C. D. et al. Endocrine-disrupting activity of hydraulic fracturing chemicals and adverse health outcomes after prenatal exposure in male mice. Endocrinology 156, 4458–4473 (2015).
pubmed: 26465197 doi: 10.1210/en.2015-1375
Kassotis, C. D. et al. Adverse reproductive and developmental health outcomes following prenatal exposure to a hydraulic fracturing chemical mixture in female C57Bl/6 mice. Endocrinology 157, 3469–3481 (2016).
pubmed: 27560547 pmcid: 5393361 doi: 10.1210/en.2016-1242
Balise, V. D. et al. Preconceptional, gestational, and lactational exposure to an unconventional oil and gas chemical mixture alters energy expenditure in adult female mice. Front. Endocrinol. 10, 323 (2019).
doi: 10.3389/fendo.2019.00323
Balise, V. D. et al. Developmental exposure to a mixture of unconventional oil and gas chemicals increased risk-taking behavior, activity and Energy expenditure in aged female mice after a metabolic challenge. Front. Endocrinol. 10, 460 (2019).
doi: 10.3389/fendo.2019.00460
Vandenberg, L. N. Endocrine disrupting chemicals and the mammary gland. Adv. Pharmacol. 92, 237–277 (2021).
pubmed: 34452688 doi: 10.1016/bs.apha.2021.04.005
Neal-Kluever, A. et al. Infant toxicology: State of the science and considerations in evaluation of safety. Food Chem. Toxicol. 70, 68–83 (2014).
pubmed: 24824476 doi: 10.1016/j.fct.2014.05.003
Cameron, J., & Abouchar, J. The precautionary principle: a fundamental principle of law and policy for the protection of the global environment. 14 BC Int’l & Comp. L. Rev. 1 (1991).
Tsai, P. L. & Hatfield, T. H. Global benefits from the phaseout of leaded fuel. J. Environ. Health 74, 8–15 (2011).
Silva, E., Rajapakse, N. & Kortenkamp, A. Something from “nothing”-eight weak estrogenic chemicals combined at concentrations below NOECs produce significant mixture effects. Environ. Sci. Technol. 36, 1751–1756 (2002).
pubmed: 11993873 doi: 10.1021/es0101227
Rajapakse, N., Silva, E. & Kortenkamp, A. Combining xenoestrogens at levels below individual no-observed-effect concentrations dramatically enhances steroid hormone action. Environ. Health Perspect. 110, 917–921 (2002).
pubmed: 12204827 pmcid: 1240992 doi: 10.1289/ehp.02110917
Christiansen, S. et al. Combined exposure to anti-androgens causes markedly increased frequencies of hypospadias in the rat. Int. J. Androl. 31, 241–248 (2008).
pubmed: 18315719 doi: 10.1111/j.1365-2605.2008.00866.x
Orton, F., Rosivatz, E., Scholze, M. & Kortenkamp, A. Competitive androgen receptor antagonism as a factor determining the predictability of cumulative antiandrogenic effects of widely used pesticides. Environ. Health Perspect. 120, 1578–1584 (2012).
pubmed: 23008280 pmcid: 3556629 doi: 10.1289/ehp.1205391
Thrupp, T. J. et al. The consequences of exposure to mixtures of chemicals: something from ‘nothing’ and ‘a lot from a little’ when fish are exposed to steroid hormones. Sci. Total Environ. 619–620, 1482–1492 (2018).
pubmed: 29734624 doi: 10.1016/j.scitotenv.2017.11.081
Yang, M., Park, M. S. & Lee, H. S. Endocrine disrupting chemicals: human exposure and health risks. J. Environ. Sci. Health C. Environ. Carcinog. Ecotoxicol. Rev. 24, 183–224 (2006).
pubmed: 17114110 doi: 10.1080/10590500600936474
Conley, J. M. et al. A mixture of 15 phthalates and pesticides below individual chemical no observed adverse effect levels (NOAELs) produces reproductive tract malformations in the male rat. Environ. Int. 156, 106615 (2021). An important study of chemical mixtures, highlighting that chemicals at doses that individually have no adverse effects can produce serious adverse effects when combined.
pubmed: 34000504 pmcid: 8380680 doi: 10.1016/j.envint.2021.106615
Martin, O. et al. Ten years of research on synergisms and antagonisms in chemical mixtures: a systematic review and quantitative reappraisal of mixture studies. Environ. Int. 146, 106206 (2021).
pubmed: 33120228 doi: 10.1016/j.envint.2020.106206
Centers for Disease Control and Prevention. National Report on Human Exposure to Environmental Chemicals https://www.cdc.gov/exposurereport/index.html (2015).
Houlihan, J. Body Burden: The Pollution in Newborns. Environmental Working Group https://www.ewg.org/research/body-burden-pollution-newborns (2005).
EFSA Scientific Committee et al. Guidance on harmonised methodologies for human health, animal health and ecological risk assessment of combined exposure to multiple chemicals. EFSA J. 17, e05634 (2019).
pmcid: 7009070 doi: 10.2903/j.efsa.2019.5634
Anzenbacher, P. & Anzenbacherová, E. Cytochromes P450 and metabolism of xenobiotics. Cell Mol. Life Sci. 58, 737–747 (2001).
pubmed: 11437235 doi: 10.1007/PL00000897
Markowitz, J. S. et al. Effect of St John’s wort on drug metabolism by induction of cytochrome P450 3A4 enzyme. J. Am. Med. Assoc. 290, 1500–1504 (2003).
doi: 10.1001/jama.290.11.1500
Kassotis, C. D., Tillitt, D. E., Lin, C. H., McElroy, J. A. & Nagel, S. C. Endocrine-disrupting chemicals and oil and natural gas operations: potential environmental contamination and recommendations to assess complex environmental mixtures. Environ. Health Perspect. 124, 256–264 (2016).
pubmed: 26311476 doi: 10.1289/ehp.1409535
Gauger, K. J. et al. Polychlorinated biphenyls 105 and 118 form thyroid hormone receptor agonists after cytochrome P4501A1 activation in rat pituitary GH3 cells. Environ. Health Perspect. 115, 1623–1630 (2007).
pubmed: 18007995 pmcid: 2072832 doi: 10.1289/ehp.10328
Hoover, G., Kar, S., Guffey, S., Leszczynski, J. & Sepúlveda, M. S. In vitro and in silico modeling of perfluoroalkyl substances mixture toxicity in an amphibian fibroblast cell line. Chemosphere 233, 25–33 (2019).
pubmed: 31163305 doi: 10.1016/j.chemosphere.2019.05.065
Ojo, A. F., Peng, C. & Ng, J. C. Combined effects and toxicological interactions of perfluoroalkyl and polyfluoroalkyl substances mixtures in human liver cells (HepG2). Environ. Pollut. 263, 114182 (2020).
pubmed: 32247900 doi: 10.1016/j.envpol.2020.114182
Ding, G. et al. Combined effects of PFOS and PFOA on zebrafish (Danio rerio) embryos. Arch. Environ. Contam. Toxicol. 64, 668–675 (2013).
pubmed: 23479250 doi: 10.1007/s00244-012-9864-2
Marques, E. S. et al. The role of maternal high fat diet on mouse pup metabolic endpoints following perinatal PFAS and PFAS mixture exposure. Toxicology 462, 152921 (2021).
pubmed: 34464680 doi: 10.1016/j.tox.2021.152921
Liew, Z. et al. Maternal plasma perfluoroalkyl substances and miscarriage: a nested case-control study in the Danish National Birth Cohort. Environ. Health Perspect. 128, 47007 (2020).
pubmed: 32319790 doi: 10.1289/EHP6202
Shih, Y. H., Blomberg, A. J., Jørgensen, L. H., Weihe, P. & Grandjean, P. Early-life exposure to perfluoroalkyl substances in relation to serum adipokines in a longitudinal birth cohort. Environ. Res 204, 111905 (2022).
pubmed: 34419464 doi: 10.1016/j.envres.2021.111905
Guo, J. et al. Umbilical cord serum perfluoroalkyl substance mixtures in relation to thyroid function of newborns: findings from Sheyang Mini Birth Cohort Study. Chemosphere 273, 129664 (2021).
pubmed: 33493812 doi: 10.1016/j.chemosphere.2021.129664
Zhuang L. H. et al. Effects of gestational exposures to chemical mixtures on birth weight using Bayesian factor analysis in the Health Outcome and Measures of Environment (HOME) Study. Environ Epidemiol. 2021;5:e159.
Preston, E. V. et al. Prenatal exposure to per- and polyfluoroalkyl substances and maternal and neonatal thyroid function in the Project Viva Cohort: a mixtures approach. Environ. Int. 139, 105728 (2020).
pubmed: 32311629 pmcid: 7282386 doi: 10.1016/j.envint.2020.105728
Luo, D. et al. Associations of prenatal exposure to per- and polyfluoroalkyl substances with the neonatal birth size and hormones in the growth hormone/insulin-like growth factor axis. Environ. Sci. Technol. 55, 11859–11873 (2021).
pubmed: 34378915 doi: 10.1021/acs.est.1c02670
Woods, M. M., Lanphear, B. P., Braun, J. M. & McCandless, L. C. Gestational exposure to endocrine disrupting chemicals in relation to infant birth weight: a Bayesian analysis of the HOME Study. Environ. Health 16, 115 (2017).
pubmed: 29078782 pmcid: 5658906 doi: 10.1186/s12940-017-0332-3
Liang, H. et al. Prenatal exposure to perfluoroalkyl substances and thyroid hormone concentrations in cord plasma in a Chinese birth cohort. Environ. Health 19, 127 (2020).
pubmed: 33243245 pmcid: 7690128 doi: 10.1186/s12940-020-00679-7
Slama, R. et al. Scientific issues relevant to setting regulatory criteria to identify endocrine-disrupting substances in the European Union. Environ. Health Perspect. 124, 1497–1503 (2016).
pubmed: 27108591 pmcid: 5047779 doi: 10.1289/EHP217
Bourguignon, J. P. et al. Science-based regulation of endocrine disrupting chemicals in Europe: which approach? Lancet Diabetes Endocrinol. 4, 643–646 (2016).
pubmed: 27312524 doi: 10.1016/S2213-8587(16)30121-8
European Chemical Agency (ECHA) and European Food Safety Authority (EFSA) with the technical support of the Joint Research Centre (JRC) et al. Guidance for the identification of endocrine disruptors in the context of Regulations (EU) No 528/2012 and (EC) No 1107/2009. EFSA J. 16, e05311 (2018).
pubmed: 32625944 doi: 10.2903/j.efsa.2018.5311
European Commission. Chemicals Strategy for Sustainability Towards a Toxic-Free Environment https://environment.ec.europa.eu/strategy/chemicals-strategy_en (2020).
O’Reilly, J. T. What REACH can teach us about TSCA: retrospectives of America’s failed Toxics Statute. Eur. J. Risk Regul. 1, 40–50 (2010).
doi: 10.1017/S1867299X00000052
Environmental Protection Agency. Cumulative Assessment of Risk from Pesticides https://www.epa.gov/pesticide-science-and-assessing-pesticide-risks/cumulative-assessment-risk-pesticides (2015).
Maffini, M. V. & Neltner, T. G. Brain drain: the cost of neglected responsibilities in evaluating cumulative effects of environmental chemicals.J. Epidemiol. Community Health 69, 496–499 (2015).
pubmed: 25336676 doi: 10.1136/jech-2014-203980
US Food and Drug Administration. CFR — Code of Federal Regulations Title 21 https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=170.18 (2022).
Federal Register. Indirect Food Additives: Paper and Paperboard Components https://www.federalregister.gov/documents/2016/01/04/2015-33026/indirect-food-additives-paper-and-paperboard-components (2016).
Keefe D. M. RE: Pre-Notification Consultation (PNC) 2422. US Food and Drug Administration https://blogs.edf.org/health/files/2021/04/Daikin-PNC-2422-PFAS_Daikin-Final-10-1-2019-and-response-combined.pdf (2019).
Brennan, N. M., Evans, A. T., Fritz, M. K., Peak, S. A. & von Holst, H. E. Trends in the regulation of Per- and polyfluoroalkyl substances (PFAS): a scoping review. Int. J. Environ. Res. Public Health 18, 10900 (2021).
pubmed: 34682663 pmcid: 8536021 doi: 10.3390/ijerph182010900
ECHA. ECHA Publishes PFAS Restriction Proposal. ECHA All News. https://echa.europa.eu/-/echa-publishes-pfas-restriction-proposal (2023).
US Consumer Product Safety Commission. The Consumer Product Safety Improvement Act of 2008 https://www.cpsc.gov/s3fs-public/pdfs/blk_pdf_cpsia.pdf (2008).
National Academies of Sciences, Engineering, and Medicine. A Class Approach to Hazard Assessment of Organohalogen Flame Retardants. National Academies Press http://www.ncbi.nlm.nih.gov/books/NBK545458/ (2019).
Babich M. A. Commission Briefing Package: Project Plan: Organohalogen Flame Retardant Chemicals Assessment. US Consumer Product Safety Commission https://www.cpsc.gov/content/Commission-Briefing-Package-Project-Plan-Organohalogen-Flame-Retardant-Chemicals-Assessment (2020).
Bevington, C. et al. Development of a flame retardant and an organohalogen flame retardant chemical inventory. Sci. Data 9, 295 (2022).
pmcid: 9192637 doi: 10.1038/s41597-022-01351-0
Payne, J., Rajapakse, N., Wilkins, M. & Kortenkamp, A. Prediction and assessment of the effects of mixtures of four xenoestrogens. Env. Health Perspect. 108, 983–987 (2000).
doi: 10.1289/ehp.00108983
Miller, M. F., Chernyak, S. M., Batterman, S. & Loch-Caruso, R. Polybrominated diphenyl ethers in human gestational membranes from women in Southeast Michigan (USA). Environ. Sci. Technol. 43, 3042–3046 (2009).
pubmed: 19534111 pmcid: 2700303 doi: 10.1021/es8032764
Jacobs, D. E. Lead screening update from the US Preventive Services Task Force. J. Pediatr. 212, 243 (2019).
pubmed: 31439165 doi: 10.1016/j.jpeds.2019.07.011
National Academies of Sciences, Engineering, and Medicine. Guidance on PFAS Exposure, Testing, and Clinical Follow-Up https://nap.nationalacademies.org/catalog/26156/guidance-on-pfas-exposure-testing-and-clinical-follow-up (2022).
Gosetti, F. et al. Study of endocrine disrupting compound release from different medical devices through an on-line SPE UHPLC-MS/MS method. Analytica Chim. Acta 1042, 141–154 (2018).
doi: 10.1016/j.aca.2018.07.028
Genco, M., Anderson-Shaw, L. & Sargis, R. M. Unwitting accomplices: endocrine disruptors confounding clinical care. J. Clin. Endocrinol. Metab. 105, e3822–e3827 (2020). Essential reading for the clinician who is concerned about exposures to EDCs in the medical setting, and how these exposures might be affecting the health of patients.
pubmed: 32614432 pmcid: 7442273 doi: 10.1210/clinem/dgaa358
Demeneix, B. A. How fossil fuel-derived pesticides and plastics harm health, biodiversity, and the climate. Lancet Diabetes Endocrinol. 8, 462–464 (2020).
pubmed: 32445732 pmcid: 7239621 doi: 10.1016/S2213-8587(20)30116-9
DeCourten, B. M. & Brander, S. M. Combined effects of increased temperature and endocrine disrupting pollutants on sex determination, survival, and development across generations. Sci. Rep. 7, 9310 (2017).
pubmed: 28839182 pmcid: 5571109 doi: 10.1038/s41598-017-09631-1
Brown, A. R. et al. Climate change and pollution speed declines in zebrafish populations. Proc. Natl Acad. Sci. 112, E1237–E1246 (2015).
pubmed: 25733876 pmcid: 4371911 doi: 10.1073/pnas.1416269112
Kulkarni, M. A., Duguay, C. & Ost, K. Charting the evidence for climate change impacts on the global spread of malaria and dengue and adaptive responses: a scoping review of reviews. Globalization Health 18, 1 (2022).
pubmed: 34980187 pmcid: 8725488 doi: 10.1186/s12992-021-00793-2
IPCC. Masson-Delmotte, V. et al. Special Report: Global Warming of 1.5°C. Summary for Policymakers 3-24 (Cambridge University Press, 2018). https://www.ipcc.ch/sr15/chapter/spm/ .
d’Ambrières, W. Plastics recycling worldwide: current overview and desirable changes. Field Actions Sci. Rep. 19, 12–21 (2019).
Turner, A. & Filella, M. Hazardous metal additives in plastics and their environmental impacts. Environ. Int. 156, 106622 (2021).
pubmed: 34030075 doi: 10.1016/j.envint.2021.106622
Kassotis, C. D. et al. Endocrine-disrupting chemicals: economic, regulatory, and policy implications. Lancet Diabetes Endocrinol. 8, 719–730 (2020). An important contribution showing how EDC policies and regulations are handled in different jurisdictions.
pubmed: 32707119 pmcid: 7437819 doi: 10.1016/S2213-8587(20)30128-5
Kahn, L. G., Philippat, C., Nakayama, S. F., Slama, R. & Trasande, L. Endocrine-disrupting chemicals: implications for human health.Lancet Diabetes Endocrinol. 8, 703–718 (2020).
pubmed: 32707118 pmcid: 7437820 doi: 10.1016/S2213-8587(20)30129-7
Kuruto-Niwa, R., Nozawa, R., Miyakoshi, T., Shiozawa, T. & Terao, Y. Estrogenic activity of alkylphenols, bisphenol S, and their chlorinated derivatives using a GFP expression system. Environ. Toxicol. Pharmacol. 19, 121–130 (2005).
pubmed: 21783468 doi: 10.1016/j.etap.2004.05.009
Chen, M. Y., Ike, M. & Fujita, M. Acute toxicity, mutagenicity, and estrogenicity of bisphenol-A and other bisphenols. Environ. Toxicol. 17, 80–86 (2002).
pubmed: 11847978 doi: 10.1002/tox.10035
Yoshihara, S. et al. Potent estrogenic metabolites of bisphenol A and bisphenol B formed by rat liver S9 fraction: their structures and estrogenic potency. Toxicol. Sci. 78, 50–59 (2004).
pubmed: 14691209 doi: 10.1093/toxsci/kfh047
Okuda, K., Fukuuchi, T., Takiguchi, M. & Yoshihara, S. Novel pathway of metabolic activation of bisphenol A-related compounds for estrogenic activity. Drug Metab. Dispos. 39, 1696–1703 (2011).
pubmed: 21636669 doi: 10.1124/dmd.111.040121
Audebert, M., Dolo, L., Perdu, E., Cravedi, J. P. & Zalko, D. Use of the γH2AX assay for assessing the genotoxicity of bisphenol A and bisphenol F in human cell lines. Arch. Toxicol. 85, 1463–1473 (2011).
pubmed: 21656223 doi: 10.1007/s00204-011-0721-2
Viñas, R. & Watson, C. S. Bisphenol S disrupts estradiol-induced nongenomic signaling in a rat pituitary cell line: effects on cell functions. Environ. Health Perspect. 121, 352–358 (2013).
pubmed: 23458715 pmcid: 3621186 doi: 10.1289/ehp.1205826
Kunikane, H. et al. Double-blind randomized control trial of the effect of recombinant human erythropoietin on chemotherapy-induced anemia in patients with non-small cell lung cancer. Int. J. Clin. Oncol. 6, 296–301 (2001).
pubmed: 11828949 doi: 10.1007/s10147-001-8031-y
Brendel, S., Fetter, É., Staude, C., Vierke, L. & Biegel-Engler, A. Short-chain perfluoroalkyl acids: environmental concerns and a regulatory strategy under REACH. Environ. Sci. Eur. 30, 9 (2018).
pubmed: 29527446 pmcid: 5834591 doi: 10.1186/s12302-018-0134-4

Auteurs

Carol Duh-Leong (C)

Department of Pediatrics, New York University Grossman School of Medicine, New York, NY, USA.

Maricel V Maffini (MV)

Independent Consultant, Frederick, MD, USA.

Christopher D Kassotis (CD)

Institute of Environmental Health Sciences and Department of Pharmacology, Wayne State University, Detroit, MI, USA.

Laura N Vandenberg (LN)

Department of Environmental Health Sciences, University of Massachusetts - Amherst, Amherst, MA, USA.

Leonardo Trasande (L)

Department of Pediatrics, New York University Grossman School of Medicine, New York, NY, USA. leonardo.trasande@nyulangone.org.
Department of Environmental Medicine, New York University Grossman School of Medicine, New York, NY, USA. leonardo.trasande@nyulangone.org.
Department of Population Health, New York University Grossman School of Medicine, New York, NY, USA. leonardo.trasande@nyulangone.org.
New York University Wagner Graduate School of Public Service, New York, NY, USA. leonardo.trasande@nyulangone.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH